PD-1 expression on NK cells has been associated with impaired proliferation and cytolytic activity in ovarian and lung cancer patients (23, 24) and preclinical studies have demonstrated an increase in NK cell-mediated cytolytic activity in response to PD-L1 blockade (25, 26). This evidence concerns the gene CD274 and lung cancer.